The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
James W. Welsh(The University of Texas MD Anderson Cancer Center), Baldassarre Stea(University of Arizona)
Cited by 114
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827
Preliminary Clinical Experience with Linear Accelerator-based Spinal Stereotactic Radiosurgery
|Neurosurgery|1995|291
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases
|JAMA Oncology|2019|226
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|93